Mepolizumab, a humanized anti–IL-5 mAb, as a treatment option for severe nasal polyposis

Philippe Gevaert(Ghent University), Nicholas Van Bruaene(Ghent University), Tom Cattaert(University of Liège), Kristel Van Steen(Montefiore Hospital), Thibaut Van Zele(Ghent University), Frederic Acke(Age UK), Natalie De Ruyck(Age UK), Katrien Blomme(Ghent University), Ana R. Sousa(GlaxoSmithKline (United Kingdom)), Richard P. Marshall(GlaxoSmithKline (United Kingdom)), Claus Bachert(Ghent University)
Journal of Allergy and Clinical Immunology
September 29, 2011
Cited by 621Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis